Dongsung Pharmaceutical faces challenges as Chairman Lee Yang-gu's appeal is rejected, confirming guilty verdict for rebate charges, while the company shows improved Q1 performance under new leadership.
#YonhapInfomax #DongsungPharmaceutical #LeeYangGu #RebateCharges #ManagementControl #CourtReceivership #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63576